ISOPT V

1
ISOPT V

• March 11-14, 2004 Monte Carlo

2
ISOPP new name ISOPT

• International Symposium of Ocular Pharmacology
  and Pharmaceutics (ISOPP)
• has been changed to
• International Symposium of Ocular Pharmacology
  and Therapeutics (ISOPT)
• as to better express the strong clinical angle
  of the symposium

3
ISOPT

• Drug development
• Implementation of novel drug products in common
  practice
• The audience
• Drug developers
• Clinicians in practice

4
ISOPT V

• History
• Geneva, 1995 287 participants
• Munich, 1997 319 participants
• Lisbon, 2000 510 participants
• Seville, 2002 423 participants
• Next
• Monte Carlo, 2004

5
ISOPT Themes

• Clinical Studies
• Endpoints
• Ethical dilemmas
• Academia-industry-regulatory bodies relationship
  
• Developmental costs
• Evidence based medicine

6
ISOPT sessions

• Cornea and ocular surface diseases
• Glaucoma
• Retina
• Inflammation Infection
• Drug delivery

7
ISOPT V specials

• Mini-Symposia
• Angiogenesis
• Antioxidants
• Imaging tools
• Neuroprotection
• Courses
• Evidence based medicine
• Submitting projects to the industry

8
Participants Expectations

• Clinicians
• A comprehensive overview
• Direct interaction with drug developers
• Industry
• Presentation of achievements
• Open discussions with regulatory agents,
  clinicians and academicians
• Formation of a platform for public address on
  topics mutual to all industry

9
See You in Monte Carlo
Hotel de Paris

• March 11 14, 2004